| 111 |
Dr. C. S. Pramesh |
Three field radical esophagectomy versus two field esophagectomy a prospective randomized controlled trial |
|
Accrual completed and follow-up ongoing |
Surgical Oncology |
Thoracic |
| 705 |
Dr. C. S. Pramesh |
Effect of screening with visual examination and double-contrast barium swallow on oral and upper aerodigestive tract cancer mortality- a cluster -randomized trial |
CTRI/2019/09/021178 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Thoracic |
| 1100 |
Dr. C. S. Pramesh |
Demographic profile of lung cancer and its treatment in India |
|
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 1640 |
Dr. Sabita Jiwnani |
Assessment of changes in hypoxia related biomarkers during surgery in resectable non-small cell lung cancer |
CTRI/2017/10/010260 |
Active enrollment ongoing |
Surgical Oncology |
Thoracic |
| 1719 |
Dr. C. S. Pramesh |
A phase III, double blind, Placebo controlled, randomized trial assessing the effect of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumor. (Add Aspirin Study) |
CTRI/2016/11/007469 |
Accrual completed and intervention ongoing |
Surgical Oncology |
Thoracic |
| 1850 |
Dr. Kumar Prabhash |
Profiling the incidence of ROS1 alteration discovered in human Non Small Cell Lung Cancer |
CTRI/2017/07/009024 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 1885 |
Dr. Amit Joshi |
A randomized trial to compare gefitinib plus chemotherapy vs chemotherapy alone in EGFR positive and T790M mutation negative advanced Non-small cell lung cancer patients after progression on first line gefitinib. |
CTRI/2018/05/013694 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 1980 |
Dr. C. S. Pramesh |
Esophagectomy Complications Platform and Quality Measures: What is the Contemporary Incidence of Complications at High Volume Esophagectomy Centers? |
CTRI/2018/01/011410 |
Active Enrollment ongoing |
Surgical Oncology |
Thoracic |
| 3002 |
Dr. Devayani Niyogi |
A randomized clinical trial evaluating the efficacy and safety of the addition of postoperative chemoradiation versus observation in patients with high-risk esophageal squamous cell carcinoma following surgery |
CTRI/2019/05/019335 |
Active enrollment ongoing |
Medical Oncology |
Thoracic |
| 3036 |
Dr. Rajiv Kumar |
Introduction of a novel, cost effective, multigene panel for NSCLC patients - A pilot project |
|
Accrual completed and intervention ongoing |
Pathology |
Thoracic |
| 3093 |
Dr. Rajiv Kumar |
Deep Learning neural network based radiogenomics in predicting clinicopathological outcomes in non-small cell lung cancer |
REF/2018/10/022102 |
Publication activities ongoing |
Radio-diagnosis |
Thoracic |
| 3109 |
Dr. Nandini Menon |
Carboplatin/paclitaxel versus cisplatin/5-fluorouracilas definitive chemoradiotherapy for locoregionally advanced unresectable esophageal and gastroesophageal junction cancer. |
CTRI/2018/08/015564 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3196 |
Dr. C. S. Pramesh |
Influence of Nutrition and SarcoPenia on Esophageal Cancer outcomes (INSPECT Study) |
CTRI/2019/01/016870 |
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 3244 |
Dr. Anil Tibdewal |
A retrospective study to evaluate survival outcomes of limited stage small cell lung cancer. |
|
Data Analysis ongoing |
Radiation Oncology |
Thoracic |
| 3338 |
Dr. Anil Tibdewal |
A Phase II Randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic non small cell lung cancer patients-TARGET-1 |
CTRI/2019/11/021872 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3352 |
Dr. Sabita Jiwnani |
Intra-operative recurrent laryngeal nerve monitoring during three field esophagectomy- a pilot study |
|
Active enrollment ongoing |
Surgical Oncology |
Thoracic |
| 3357 |
Dr. Anil Tibdewal |
A Prospective Observational Study of longitudinal assessment of neurocognitive function in patients with 1-4 brain metastases of NSCLC treated with Cranial Irradiation |
CTRI/2019/10/021511 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3368 |
Dr. C. S. Pramesh |
Distribution of lymph node metastases in esophageal carcinoma. (TIGER Study) |
CTRI/2019/10/021526 |
Active Enrollment ongoing |
Surgical Oncology |
Thoracic |
| 3376 |
Dr. Nandini Menon |
Carboplatin / Paclitaxel Versus Cisplatin/ Etoposide as Definitive Chemoradiotherapy for LocoRegionally advanced Non small Lung cancer (NSCLC): A Phase III Randomized Controlled Trial |
CTRI/2020/03/023770 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3394 |
Dr. Anil Tibdewal |
A phase III randomized controlled trial of two radiotherapy fractionation regimens in metastatic epidural spinal cord compression in lung cancer patients |
CTRI/2020/04/024707 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3408 |
Dr. C. S. Pramesh |
Patient perception of 'meaningful benefit' from palliative chemotherapy in metastatic lung cancer - A survey |
CTRI/2022/01/039563 |
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 3439 |
Dr. C. S. Pramesh |
Grid Oncology: Remaking Cancer Care in India |
CTRI/2020/06/025784 |
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 3440 |
Dr. Kumar Prabhash |
Randomised Control Trial Comparing Nanosomal Docetaxel Lipid Suspension (NDLS) Vs Docetaxel As Second Line Therapy In Palliative Setting Of Non Small Cell Lung Cancer |
CTRI/2020/05/025302 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3442 |
Dr. Kumar Prabhash |
An open label, randomized, clinical trial of Mycobacterium w (Mw) as an Adjuvant to chemotherapy in Advanced Non-small Cell Lung Cancer |
CTRI/2020/09/027853 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3445 |
Dr. Anil Tibdewal |
Standard Maintenance Therapy versus Local Consolidation Radiation Therapy and Standard Maintenance Therapy In 1-5 sites of oligometastatic Non-Small Cell Lung Cancer (NSCLC) - A Phase III Randomized Controlled Trial (TARGET-2) |
CTRI/2020/04/024761 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3448 |
Dr. Anil Tibdewal |
A Prospective Observational Study on Outcomes of Bone Metastases treated with Radiotherapy in Lung Cancer |
CTRI/2020/04/024780 |
Active Enrollment ongoing |
Radiation Oncology |
Thoracic |
| 3470 |
Dr. Anil Tibdewal |
Observation or upfront cranial RT in oncogene driver mutated NSCLC with asymptomatic brain metastases: A phase III Randomized Controlled Trial |
CTRI/2020/08/027279 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3485 |
Dr. Jai Prakash Agarwal |
Whole brain radiation therapy plus Resveratrol-Copper in brain metastases patients of non small cell lung cancer - A Phase II Randomized controlled trial. |
CTRI/2020/09/027794 |
Active accrual and intervention ongoing |
Radiation Oncology |
Thoracic |
| 3530 |
Dr. Vanita Noronha |
Optimizing chemotherapy in the first line for frail older patients with advanced non-small cell lung cancer. |
CTRI/2022/07/044193 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3589 |
Dr. Vanita Noronha |
A Randomized Study to compare Gefitinib to Gefitinib with Chemotherapy in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients with Compromised Performance Status. |
CTRI/2022/08/044570 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3624 |
Dr. Vanita Noronha |
Protocol No. - 61186372NSC3001 : A Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared with Carboplatin-Pemetrexed, in Patients with EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer. |
CTRI/2020/11/029081 |
Accrual completed and intervention ongoing |
Medical Oncology |
Thoracic |
| 3637 |
Dr. Kumar Prabhash |
Protocol No. - 73841937NSC3003 : A Phase 3, Randomized study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients with EGFR-Mutated LocallyAdvanced or Metastatic Non-Small Cell Lung Cancer_x000D_\n |
CTRI/2020/11/029082 |
Accrual completed and intervention ongoing |
Medical Oncology |
Thoracic |
| 3753 |
Dr. Suyash Kulkarni |
Evaluation of AI performance in detecting lung opacities in chest radiograph and characterizing them into different subgroups (atelectasis, calcification, cardiomegaly, fibrosis, mediastinal widening, nodule, and pleural effusion). |
CTRI/2022/04/041873 |
Active Enrollment ongoing |
Radio-diagnosis |
Thoracic |
| 3761 |
Dr. Anil Tibdewal |
Locally Ablative Therapy for Oligo-Progressive, Oligo-Recurrent and Oligo-Persistent Non-Small Cell Lung Cancer - An Ambispective Observational Cohort study (OLIGO-CHROME) |
NIL |
Active Enrollment ongoing |
Radiation Oncology |
Thoracic |
| 3805 |
Dr. Sabita Jiwnani |
Frailty indices for predicting postoperative complications after esophagectomy |
|
Active Enrollment ongoing |
Surgical Oncology |
Thoracic |
| 3865 |
Dr. C. S. Pramesh |
Developing precision immunotherapy for value-based treatment of lung cancer in India |
CTRI/2022/05/042559 |
Active enrollment ongoing |
Surgical Oncology |
Thoracic |
| 3874 |
Dr. Sabita Jiwnani |
PROspective assessment of TOXicity burden in ESOphageal cancer patients undergoing neoadjuvant chemo-radiation therapy (PROTOX-ESO) |
|
Active enrollment ongoing |
Radiation Oncology |
Thoracic |
| 3896 |
Dr. Aparna Chatterjee |
Persistent pain following thoracic surgery |
CTRI/2022/03/040867 |
Data Analysis ongoing |
Anaesthesia |
Thoracic |
| 3907 |
Dr. Kumar Prabhash |
Protocol No. - 61186372NSC3002 : A Phase 3, Open-Label, Randomized Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in Patients with EGFR-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure |
CTRI/2022/01/039158 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Thoracic |
| 3932 |
Dr. Nandini Menon |
Protocol No. - D967SC00001 : An Open-label, Randomized, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Trastuzumab Deruxtecan as First-line _x000D_\nTreatment of Unresectable, Locally Advanced, or Metastatic NSCLC Harboring HER2 Exon 19 or 20 Mutations (DESTINY-Lung04) |
CTRI/2022/02/040116 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 3938 |
Dr. Swapnil Parab |
An ambi-directional observational study to find out the efficacy and side effect profile of _x000D_\nanalgesic modalities used in minimally invasive esophagectomy (MIE) surgeries at a tertiary care _x000D_\ncancer centre. |
CTRI/2022/06/43549 |
Publication activities ongoing |
Anaesthesia |
Thoracic |
| 3973 |
Dr. Nandini Menon |
Protocol No. - CA-170-302 : A Phase IIb/III, Randomised, Double-blind, Placebo-controlled, Multicentre, Study of CA-170 in Combination with Chemotherapy in Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer (ASIAD-3). |
CTRI/2021/10/037699 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Thoracic |
| 4031 |
Dr. Nandini Menon |
ATORG Molecular Profiling Project |
CTRI/2022/12/048326 |
Not started/Not initiated |
Medical Oncology |
Thoracic |
| 4035 |
Dr. Vanita Noronha |
Protocol No. - CINC280AIN01 : A Prospective, Multicenter, Open-Label, Phase IV, Interventional Study To Assess The Safety And Efficacy Of Capmatinib In Indian Patients With Mesenchymal-Epithelial Transition (MET) Exon 14 Skipping Mutation Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)_x000D_\n |
CTRI/2022/05/042549 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Thoracic |
| 4063 |
Dr. Anant Ramaswamy |
A multicentric, double blinded, prospective observational cohort study to validate the CARG score as a predictor of >= grade 3 chemotherapy toxicities in older Indian patients with cancer receiving chemotherapy (CARG-IND). |
CTRI/2022/10/046865 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 4078 |
Dr. Amit Joshi |
Protocol No. - J2G-MCJZJX : LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib following Definitive Locoregional Treatment in Participants with Stage IB-IIIA RET fusion-Positive NSCLC |
CTRI/2022/09/046009 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Thoracic |
| 4094 |
Dr. Anil Tibdewal |
Validation of Lung-specific Graded Prognostic Assessment Score in Brain Metastases - An ambispective validation study |
CTRI/2023/03/050413 |
Active enrollment ongoing |
Radiation Oncology |
Thoracic |
| 4100 |
Dr. Nivedita Chakrabarty |
Deep learning based quantification of PD-L1 expression on CT images in advanced stage non-small cell lung cancer (NSCLC) patients and its correlation with overall survival |
|
Active Enrollment ongoing |
Radio-diagnosis |
Thoracic |
| 4135 |
Dr. Nandini Menon |
Phase 3 randomized study for evaluation of addition of Pembrolizumab to palliative therapy in NSCLC |
CTRI/2023/08/056715 |
Active enrollment ongoing |
Medical Oncology |
Thoracic |
| 4215 |
Dr. Swapnil Parab |
A randomized controlled, double blinded study to test the efficacy of Protective One Lung Ventilation Bundle in prevention of Post Operative Pulmonary Complications following elective major lung resection surgeries in a tertiary care cancer institute. |
CTRI/2023/10/058887 |
Active Enrollment ongoing |
Anaesthesia |
Thoracic |
| 4231 |
Dr. Virendrakumar Tiwari |
Phase 2 pilot study to test the efficacy of Ayurvedic oral cannabis preparation in the peri-operative period in Non-small cell lung cancer_x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Thoracic |
| 4257 |
Dr. Madhavi Shetmahajan |
A Prospective Randomised Controlled Trial To Compare The Stability Of Bronchial Blocker Between Extraluminal And Intraluminal Placement In Adult Thoracic Surgery. |
CTRI/2024/04/066317 |
Active Enrollment ongoing |
Anaesthesia |
Thoracic |
| 4267 |
Mrs. Manali Kamat |
Effect of pre-operative exercise training in resectable esophageal cancers- a feasibility study |
CTRI/2024/06/069472 |
Active accrual and intervention ongoing |
Physiotherapy |
Thoracic |
| 4276 |
Dr. Anil Tibdewal |
The Impact of Radiation Therapy doses on Cardiac Toxicity and Survival in Thoracic Malignancies - An Ambispective Observational Study |
CTRI/2024/01/061777 |
Active enrollment ongoing |
Radiation Oncology |
Thoracic |
| 4310 |
Dr. Vanita Noronha |
A retrospective review of the pattern of care of systemic therapy in lung cancer |
|
Case review/sample review ongoing (audit studies) |
Medical Oncology |
Thoracic |
| 4323 |
Dr. Kumar Prabhash |
Phase III RCT comparing chemotherapy to chemotherapy plus immunotherapy in patients with advanced esophageal squamous cell cancer receiving first line palliative intent systemic therapy (NICE Study). |
CTRI/2024/03/064939 |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 4362 |
Dr. Nandini Menon |
Non-Interventional Study - Use of lorlatinib in treatment-naive adult patients with metastatic or locally advanced anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) from India. |
CTRI/2024/03/063721 |
Case review/sample review ongoing (audit studies) |
Medical Oncology |
Thoracic |
| 4369 |
Dr. Swapnil Parab |
Prospective observational study to assess the efficacy and safety of Thoracoscopic guided Paravertebral Block (TGPVB) in Uniportal minimally invasive lung resection surgeries at a tertiary care cancer centre |
CTRI/2024/04/065006 |
Active Enrollment ongoing |
Anaesthesia |
Thoracic |
| 4374 |
Dr. Swapnil Parab |
A prospective pilot observational study to assess the preoperative functional status of patients undergoing esophagectomy surgery using a pedometer and its correlation with postoperative pulmonary complications and surgical outcomes |
CTRI/2024/07/071643 |
Active Enrollment ongoing |
Anaesthesia |
Thoracic |
| 4377 |
Mrs. Prathepa Jagdish |
Focused breathing exercises in prevention of postoperative pulmonary complications in lung cancer patients undergoing lung cancer surgery at tertiary care centre, Mumbai. |
CTRI/2024/07/069937 |
Accrual completed and intervention ongoing |
Nursing Services |
Thoracic |
| 4400 |
Dr. Madhavi Shetmahajan |
PROSPECTIVE OBSERVATIONAL STUDY OF PERIOPERATIVE AIRWAY MANAGEMENT IN ADULT PATIENTS WITH CENTRAL AIRWAY OBSTRUCTION |
CTRI/2024/06/066317 |
Active Enrollment ongoing |
Anaesthesia |
Thoracic |
| 4429 |
Dr. Rajiv Kumar |
Clinicopathological Features of Primary Pulmonary Hepatoid Adenocarcinomas:An Under-Recognised and Aggressive Lung Neoplasm_x000D_\n_x000D_\n |
|
Accrual completed and intervention ongoing |
Pathology |
Thoracic |
| 4439 |
Dr. Kumar Prabhash |
Real-World Indian Registry Study of Atezolizumab in Lung Cancer Tecentriq® Lung Registry |
CTRI/2024/01/061362 |
Not started/Not initiated |
Medical Oncology |
Thoracic |
| 4457 |
Dr. Kumar Prabhash |
A randomized, double-blind, parallel-group study tocompare efficacy, safety, and immunogenicity of GME751(proposed pembrolizumab biosimilar) and EU-authorizedKeytruda® in adult participants with untreated metastaticnon-squamous non-small cell lung cancer (NSCLC) |
CTRI/2025/01/079282 |
Accrual completed and intervention ongoing |
Medical Oncology |
Thoracic |
| 4459 |
Dr. Sabita Jiwnani |
A RETROSPECTIVE ANALYSIS OF RESECTION OF PULMONARY METASTASES FROM SOFT TISSUE SARCOMAS IN A TERTIARY CARE CENTRE IN INDIA_x000D_\n_x000D_\n |
|
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 4485 |
Dr. Kumar Prabhash |
A phase I/III, randomised, double blind, multicentre, parallel arm, clinical study comparing the efficacy, safety, immunogenicity and pharmacokinetics of proposed biosimilar nivolumab (DRL_NU) with nivolumab reference medicinal product (OPDIVO®) administered by the intravenous route in patients previously treated for locally advanced or metastatic non-small cell lung cancer (NSCLC). |
CTRI/2024/04/066248 |
Accrual completed and intervention ongoing |
Medical Oncology |
Thoracic |
| 4488 |
Dr. Kumar Prabhash |
A Phase III Randomised, Double-blind, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity between SB27 (proposed pembrolizumab biosimilar) and Keytruda in Subjects with Metastatic Non- squamous Non-small Cell Lung Cancer |
CTRI/2024/02/062975. |
Active Enrollment ongoing |
Medical Oncology |
Thoracic |
| 4495 |
Dr. Sabita Jiwnani |
Prognostic implications of circumferential resection margin after curative esophagectomy -a retrospective analysis |
|
Data Analysis ongoing |
Surgical Oncology |
Thoracic |
| 4496 |
Dr. Kumar Prabhash |
A Phase II, Open-label, Single-arm Study of Osimertinib as Induction Therapy Prior to CRT and Maintenance Osimertinib in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Stage III, Unresectable Non-small Cell Lung Cancer (NEOLA) |
CTRI/2024/06/069176 |
Data Analysis ongoing |
Medical Oncology |
Thoracic |
| 4505 |
Dr. Nilendu Purandare |
Response assessment of Immune check point inhibitors(ICI) using [18-F]-FDG PET-CT in non small cell lung cancers (NSCLC) |
|
Approved |
Nuclear Medicine |
Thoracic |
| 4508 |
Dr. Kumar Prabhash |
A multi-centre, multi-country real world study of treatment outcomes in ALK rearranged NSCLC |
|
Not started/Not initiated |
Medical Oncology |
Thoracic |
| 4534 |
Dr. Sandeep Tandon |
RETROSPECTIVE STUDY OF TUBERCULOSIS IN A TERTIARY CANCER CENTRE |
|
Data Analysis ongoing |
Pulmonary Medicine |
Thoracic |
| 4544 |
Dr. Kumar Prabhash |
A Phase 1, Multicenter, Open-Label, Dose Escalation/Consolidation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Orally Administered JBI-778 in EGFR Mutated Lung Cancer Patients with or without Brain Metastasis, Isocitrate Dehydrogenase (IDH) Mutated WHO Grade 3/4 Recurrent Glioma and Adenoid Cystic Carcinoma (ACC) |
CTRI/2024/07/070802 |
Approved |
Medical Oncology |
Thoracic |
| 4555 |
Dr. Kumar Prabhash |
MASTER SCREENING STUDY TO DETERMINE BIOMARKER STATUS AND POTENTIAL TRIAL ELIGIBILITY FOR PATIENTS WITH MALIGNANT TUMORS |
CTRI/2024/09/074249 |
On Hold |
Medical Oncology |
Thoracic |
| 4557 |
Dr. Vanita Noronha |
A PHASE I-III, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE THERAPIES IN COHORTS OF PATIENTS SELECTED ACCORDING TO BIOMARKER STATUS, WITH LOCALLY ADVANCED, UNRESECTABLE, STAGE III NON-SMALL CELL LUNG CANCER |
CTRI/2024/10/074537 |
On Hold |
Medical Oncology |
Thoracic |
| 4565 |
Dr. Minit Shah |
A Phase III Randomized Controlled Trial Comparing Neoadjuvant Triple-Drug Chemotherapy Plus Low-Dose Immunotherapy Versus _x000D_\nNeoadjuvant Chemoradiation in Patients with Locally Advanced Resectable Esophageal Squamous Cell Carcinoma |
CTRI/2024/11/076896 |
Active enrollment ongoing |
Medical Oncology |
Thoracic |
| 4595 |
Dr. Vanita Noronha |
DEVELOPMENT OF A GERIATRIC INDIAN SOCIAL SUPPORT QUESTIONNAIRE (GISQ) SCALE FOR OLDER PATIENTS WITH CANCER IN INDIA_x000D_\n_x000D_\n |
CTRI/2025/02/079928 |
Study Initiated and Recruitment Started |
Medical Oncology |
Thoracic |
| 4596 |
Dr. Nandini Menon |
Phase III RCT comparing triplet neoadjuvant chemotherapy with triplet neoadjuvant chemoimmunotherapy in patients with locally advanced resectable esophageal squamous carcinoma_x000D_\n_x000D_\n |
CTRI/2025/02/080989 |
Approved |
Medical Oncology |
Thoracic |
| 4606 |
Dr. Karthik V |
Contiguous multiorgan resections in invasive mediastinal tumors-A retrospective analysis_x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Thoracic |
| 4612 |
Dr. Anshu Punjabi |
Profile of patients with co-existing Lung cancer (LC) and Interstitial lung disease (ILD): A retrospective study from an Indian tertiary cancer care center._x000D_\n_x000D_\n |
|
Approved |
Pulmonary Medicine |
Thoracic |
| 4613 |
Dr. Kumar Prabhash |
A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Non squamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors |
|
Approved |
Medical Oncology |
Thoracic |
| 4616 |
Dr. Minit Shah |
Neoadjuvant chemotherapy with low dose immunotherapy in resectable non-small cell lung cancer - A phase II open label single arm study |
CTRI/2025/02/081029 |
Study Initiated and Recruitment Started |
Medical Oncology |
Thoracic |
| 4622 |
Dr. Amit Joshi |
SUNRAY-01, A Global Pivotal Study in Participants with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First_x0002_Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in those with PD-L1 expression >=50% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum regardless of PD-L1 Expression. _x000D_\n_x000D_\n |
CTRI/2024/12/077822 |
Approved |
Medical Oncology |
Thoracic |
| 4627 |
Dr. Vanita Noronha |
An open-label randomized study to compare reduced dose lorlatinib to crizotinib as first line palliative intent therapy for patients with ALK-rearranged non-small cell lung cancer |
CTRI/2025/02/079987 |
Study Initiated and Recruitment Started |
Medical Oncology |
Thoracic |
| 4629 |
Dr. Kumar Prabhash |
Liquid biopsy guided addition of chemotherapy with TKI in advanced EGFR mutated NSCLC: An open-label, multicentric, phase 3 randomized controlled trial (LiquiACT) |
NO |
Study Initiated and Recruitment Started |
Medical Oncology |
Thoracic |
| 4632 |
Dr. Manjusha Vagal |
ENERGY DEMANDS AND FUNCTIONAL CHALLENGES IN SURGICALLY TREATED LUNG CANCER PATIENTS |
|
Approved |
Occupational Therapy |
Thoracic |
| 4633 |
Dr. Bindiya Salunke |
A prospective interventional pilot study comparing pain relief following an ultrasound-guided Serratus Anterior Plane block in patients undergoing minimally invasive esophagectomy at a tertiary care cancer center, versus retrospectively collected data on standard acute pain management practices. |
|
Approved |
Anaesthesia |
Thoracic |
| 4667 |
Dr. Karthik V |
Contemporary series on pneumonectomy for metastasis to lung in solid tumors-A retrospective analysis |
|
Approved |
Surgical Oncology |
Thoracic |
| 4676 |
Dr. Sharayu Mhatre |
The role of microRNAs as biomarkers of asbestos-related lung cancers: A Pilot Study. |
|
Not started/Not initiated |
Centre For Cancer Epidemiology |
Thoracic |
| 4691 |
Ms. Jyotiben Patel |
The Effects Of Reiki Therapy On Anxiety ,Pain and Symptom Management, In Patients Receiving Cancer Treatment In a Tertiary Cancer Hospital: A Pilot Study |
CTRI/2025/08/111973 |
Approved |
Medical Oncology |
Thoracic |
| 4692 |
Dr. Kumar Prabhash |
An open label phase-2 randomized-clinical-trial to evaluate the efficacy and safety of low-dose nivolumab and low-dose chemotherapy in patients of advanced NSCLC with poor PS |
CTRI/2025/03/082809 |
Approved |
Medical Oncology |
Thoracic |
| 4742 |
Dr. Trupti Pai |
Small Cell Lung Carcinoma: Comprehensive Immunohistochemical , Histopathologic and Molecular Characterization |
|
Approved |
Pathology |
Thoracic |
| 4757 |
Dr. Subhash Desai |
Retrospective analysis of diagnostic accuracy of CT guided mediastinal mass biopsy |
|
Approved |
Radio-diagnosis |
Thoracic |
| 4768 |
Dr. Vanita Noronha |
Unmet Supportive Care Needs among Indian Geriatric Cancer Patients. |
CTRI/2025/10/095729 |
Approved |
Medical Oncology |
Thoracic |
| 4777 |
Mrs. Manali Kamat |
Co-relation between Muscle strength & Cancer related fatigue in advanced Lung Cancer in a Tertiary cancer hospital |
|
Approved |
Physiotherapy |
Thoracic |
| 4792 |
Dr. Kumar Prabhash |
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (>=50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (Be6A Lung-02) |
|
Approved |
Medical Oncology |
Thoracic |
| 4806 |
Dr. Minit Shah |
Phase 2, Open-Label, Randomized Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Evixapodlin Administered as 2nd Line Monotherapy in Subjects with Advanced Non-Small Cell Lung Cancer Expressing PD-L1 |
|
Approved |
Medical Oncology |
Thoracic |
| 4823 |
Dr. Amit Janu |
Beyond the Basics: Radiological Assessment of benign and malignant Pleural Solitary Fibrous Tumors. |
|
Approved |
Radio-diagnosis |
Thoracic |
| 4826 |
Dr. Karthik V |
Surgically resected chondroid tumors of the chest wall -A retrospective analysis_x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Thoracic |
| 4836 |
Dr. Karthik V |
OMentum Around Neck Anastomosis (OMANA) trial- A phase II, prospective, single-arm interventional) trial of omental wrapping around cervical esophagogastric anastomosis after esophagectomy |
|
Approved |
Surgical Oncology |
Thoracic |
| 4850 |
Dr. Kumar Prabhash |
A Phase 2 Trial of Adagrasib Monotherapy and in Combination with Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination with Pembrolizumab versus Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation ( Krystal 7) |
|
Approved |
Medical Oncology |
Thoracic |
| 4905 |
Dr. Priya Ranganathan |
Predictive ability of American College of Surgeons Surgical Risk Calculator in patients undergoing anatomical lung resection - a retrospective study |
|
Approved |
Anaesthesia |
Thoracic |